It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Glaxo shares rally as Elliott said to have built 'significant' stake

Thu 15 April 2021 12:33 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - GlaxoSmithKline shares shot higher on Thursday as it emerged that activist hedge fund Elliott Management has built a multibillion-pound stake in the pharmaceuticals company.

According to the Financial Times, which cited a person with knowledge of the investment, the stake taken is "significant".

Glaxo announced last February that it was planning to split into two businesses: biopharma and consumer healthcare.

The FT said one person "familiar with the mood of some GSK shareholders" suggested that investors would rather chief executive Emma Walmsley - who has no background in science - ran the consumer health business than the demerged pharma business, as planned.

Walmsley took over as CEO in April 2017, having previously run the consumer healthcare segment, and the shares have fallen 14% since then.

At 1445 BST, the shares were up 5.6% at 1,360.20p.

Glaxo declined to comment on the FT story.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.

    More company news from ShareCast